The possible underlying mechanisms can be related to desensitization of insulin signalling in brains (i.e. attributed to obesity and T2DM), impaired insulin function in the CNS, and attenuated sensitivity of insulin receptors. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.